Remdesivir IP Impurity C

Remdesivir IP Impurity C or (S)-2-ethylbutyl 2-(((S)-(((3aR,4R,6R,6aR)-6-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-6-cyano-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate,used to treat acute respiratory syndrome coronavirus 2 and inhibited by a class of drugs known as nucleoside analogues.

Additional information on Remdesivir IP Impurity C

Catalogue No.

VE008311

CAS No.

N/A

Molecular Formula

C30H39N6O8P

Molecular Weight

642.64 g/mol

Parent drug

Remdesivir

IUPAC Name

(S)-2-ethylbutyl 2-(((S)-(((3aR, 4R, 6R, 6aR)-6-(4-aminopyrrolo[2, 1-f][1, 2, 4]triazin-7-yl)-6-cyano-2, 2-dimethyltetrahydrofuro[3, 4-d][1, 3]dioxol-4-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate

Synonyms

N/A

References

Frediansyah, Andri, et al. “Remdesivir and Its Antiviral Activity against COVID-19: A Systematic Review.” Clinical Epidemiology and Global Health, vol. 9, Jan. 2021, pp. 123–27, https://doi.org/10.1016/j.cegh.2020.07.011. ?

Status

In-stock

[rfq_list]

Login first to add product to RFQ List

Request a quote

Remdesivir IP Impurity C

Remdesivir IP Impurity C
Catalogue No.

VE008311

CAS No.

N/A

Molecular Formula

C30H39N6O8P

Molecular Weight

642.64 g/mol

Parent drug

Remdesivir

IUPAC Name

(S)-2-ethylbutyl 2-(((S)-(((3aR, 4R, 6R, 6aR)-6-(4-aminopyrrolo[2, 1-f][1, 2, 4]triazin-7-yl)-6-cyano-2, 2-dimethyltetrahydrofuro[3, 4-d][1, 3]dioxol-4-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate

Synonyms

N/A

References

Frediansyah, Andri, et al. “Remdesivir and Its Antiviral Activity against COVID-19: A Systematic Review.” Clinical Epidemiology and Global Health, vol. 9, Jan. 2021, pp. 123–27, https://doi.org/10.1016/j.cegh.2020.07.011. ?

Status

In-stock

ListName

Remdesivir IP Impurity C

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden